Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ZAROXOLYN

METOLAZONE

Standard Dose
2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ZAROXOLYN is listed in Drugs@FDA under application 017386 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient METOLAZONE Form and strength TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor I3 PHARMS Submission history Latest submission status date: 2019-05-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZAROXOLYN is listed in Drugs@FDA under application 017386 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METOLAZONE Form and strength TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor I3 PHARMS Submission history Latest submission status date: 2019-05-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.